JP Patent
JP6286011B2 — 貼付剤
Assigned to Hisamitsu Pharmaceutical Co Inc · Expires 2018-02-28 · 8y expired
What this patent protects
Patent listed against Saphris.
Drugs covered by this patent
- Saphris (ASENAPINE) · Hisamitsu
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.